Shanghai, China

Tatchi Teddy Yang

USPTO Granted Patents = 5 

Average Co-Inventor Count = 10.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
5 patents (USPTO):

Title: Tatchi Teddy Yang: Innovator in Monoclonal Antibody Development

Introduction

Tatchi Teddy Yang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of five patents to his name, Yang is recognized for his innovative approaches to cancer treatment and immune modulation.

Latest Patents

Yang's latest patents include groundbreaking work on an anti-human LAG-3 monoclonal antibody. This invention discloses an antibody that targets LAG-3, along with its preparation method and applications. The novel monoclonal antibody exhibits high specificity and affinity for LAG-3 antigens, demonstrating significant anti-tumor activity. Another notable patent is for a 4-1BB antibody, which effectively activates downstream signaling and enhances the expression of key cytokines such as IFN-γ and IL-2 in human lymphocytes. This antibody holds promise for treating cancers and autoimmune diseases.

Career Highlights

Throughout his career, Tatchi Teddy Yang has worked with several notable companies, including Pharmaexplorer Limited and Shanghai Hyamab Biotech Co., Ltd. His work in these organizations has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.

Collaborations

Yang has collaborated with esteemed colleagues in the field, including Lile Liu and Qing Duan. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in biotechnology.

Conclusion

Tatchi Teddy Yang is a distinguished inventor whose work in monoclonal antibodies is paving the way for new treatments in oncology and immunology. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…